{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:28Z","timestamp":1792098568815,"version":"4.4.0"},"reference-count":59,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":467,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/bcp.12283","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T11:41:33Z","timestamp":1384342893000},"page":"958-964","source":"Crossref","is-referenced-by-count":59,"title":["Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review"],"prefix":"10.1111","volume":"77","author":[{"given":"Valentina G.","family":"Dell'Orto","sequence":"first","affiliation":[{"name":"Department of Pediatrics; San Giovanni Hospital; Bellinzona Switzerland"},{"name":"University of Berne; Berne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva A.","family":"Belotti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; San Giovanni Hospital; Bellinzona Switzerland"},{"name":"University of Berne; Berne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Goeggel-Simonetti","sequence":"additional","affiliation":[{"name":"University of Berne; Berne Switzerland"},{"name":"Pediatric Neurology; University Children's Hospital Berne; Berne Switzerland"},{"name":"Department of Neurology; University Hospital Berne; Berne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo D.","family":"Simonetti","sequence":"additional","affiliation":[{"name":"University of Berne; Berne Switzerland"},{"name":"Pediatric Nephrology; University Children's Hospital Berne; Berne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Paolo","family":"Ramelli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; San Giovanni Hospital; Bellinzona Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario G.","family":"Bianchetti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; San Giovanni Hospital; Bellinzona Switzerland"},{"name":"University of Berne; Berne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano A. G.","family":"Lava","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; San Giovanni Hospital; Bellinzona Switzerland"},{"name":"University of Berne; Berne Switzerland"},{"name":"Pediatric Nephrology; University Children's Hospital Berne; Berne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"10.1111\/bcp.12283-BIB0001|bcp12283-cit-0001","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0149-2918(08)80045-8","article-title":"Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy","volume":"30","author":"Ben-Menachem","year":"2008","journal-title":"Clin Ther"},{"key":"10.1111\/bcp.12283-BIB0002|bcp12283-cit-0002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clinthera.2005.02.013","article-title":"Topiramate monotherapy in epilepsy and migraine prevention","volume":"27","author":"Silberstein","year":"2005","journal-title":"Clin Ther"},{"key":"10.1111\/bcp.12283-BIB0003|bcp12283-cit-0003","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/14740338.6.5.547","article-title":"Increased propensity for calcium phosphate kidney stones with topiramate use","volume":"6","author":"Vega","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/bcp.12283-BIB0004|bcp12283-cit-0004","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2125.2009.03521.x","article-title":"Effect of topiramate on acid-base balance: extent, mechanism and effects","volume":"68","author":"Mirza","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/bcp.12283-BIB0005|bcp12283-cit-0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1111\/bcp.12283-BIB0006|bcp12283-cit-0006","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1476-5381.2011.01649_1.x","article-title":"Guide to Receptors and Channels (GRAC), 5th edition","volume":"164","author":"Alexander","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bcp.12283-BIB0007|bcp12283-cit-0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"Suppl 1","key":"10.1111\/bcp.12283-BIB0008|bcp12283-cit-0008","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1111\/j.1528-1157.2000.tb02176.x","article-title":"Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group","volume":"41","author":"Abou-Khalil","year":"2000","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0009|bcp12283-cit-0009","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpn.2009.11.004","article-title":"Chronic impact of topiramate on acid-base balance and potassium in childhood","volume":"14","author":"Belotti","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1111\/bcp.12283-BIB0010|bcp12283-cit-0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yebeh.2004.03.002","article-title":"Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center","volume":"5","author":"Bootsma","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1111\/bcp.12283-BIB0011|bcp12283-cit-0011","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1590\/S0004-282X2005000300032","article-title":"Topiramate and severe metabolic acidosis: case report","volume":"63","author":"Burmeister","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1111\/bcp.12283-BIB0012|bcp12283-cit-0012","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.genhosppsych.2012.04.008","article-title":"Hallucinations and comorbid renal tubular acidosis caused by topiramate in a patient with psychiatric history","volume":"35","author":"Cheng","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/bcp.12283-BIB0013|bcp12283-cit-0013","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-1211(02)00103-1","article-title":"Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study","volume":"51","author":"Coppola","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1111\/bcp.12283-BIB0014|bcp12283-cit-0014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0920-1211(02)00010-4","article-title":"Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial","volume":"49","author":"Coppola","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1111\/bcp.12283-BIB0015|bcp12283-cit-0015","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1526-4610.2007.00921.x","article-title":"Migraine and topiramate induced dyspnea","volume":"47","author":"Delpirou-Nouh","year":"2007","journal-title":"Headache"},{"key":"10.1111\/bcp.12283-BIB0016|bcp12283-cit-0016","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1345\/aph.1E437","article-title":"Impact of topiramate on serum bicarbonate concentrations in adults","volume":"39","author":"Garris","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1111\/bcp.12283-BIB0017|bcp12283-cit-0017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pediatrneurol.2008.11.004","article-title":"Urolithiasis with topiramate in nonambulatory children and young adults","volume":"40","author":"Goyal","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1111\/bcp.12283-BIB0018|bcp12283-cit-0018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1460-9592.2005.01415.x","article-title":"Topiramate and metabolic acidosis: a case series and review of the literature","volume":"15","author":"Groeper","year":"2005","journal-title":"Paediatr Anaesth"},{"key":"10.1111\/bcp.12283-BIB0019|bcp12283-cit-0019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjmed.2003.08.021","article-title":"Topiramate-induced renal tubular acidosis","volume":"116","author":"Izzedine","year":"2004","journal-title":"Am J Med"},{"key":"10.1111\/bcp.12283-BIB0020|bcp12283-cit-0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.urology.2010.06.048","article-title":"Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate","volume":"77","author":"Kaplon","year":"2011","journal-title":"Urology"},{"key":"10.1111\/bcp.12283-BIB0021|bcp12283-cit-0021","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1017\/S0012162201001268","article-title":"Topiramate-induced metabolic acidosis: report of two cases","volume":"43","author":"Ko","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/bcp.12283-BIB0022|bcp12283-cit-0022","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1526-4610.2007.01008.x","article-title":"Serum uric acid and lipid levels while taking topiramate for migraine","volume":"48","author":"Ko\u00e7er","year":"2008","journal-title":"Headache"},{"key":"10.1111\/bcp.12283-BIB0023|bcp12283-cit-0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/089277902753752188","article-title":"Topiramate-induced nephrolithiasis","volume":"16","author":"Kuo","year":"2002","journal-title":"J Endourol"},{"key":"10.1111\/bcp.12283-BIB0024|bcp12283-cit-0024","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1258\/000456304322880104","article-title":"Topiramate increases biochemical risk of nephrolithiasis","volume":"41","author":"Lamb","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/bcp.12283-BIB0025|bcp12283-cit-0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0887-8994(99)00143-5","article-title":"Central hyperventilation related to administration of topiramate","volume":"22","author":"Laskey","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1111\/bcp.12283-BIB0026|bcp12283-cit-0026","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00240-010-0347-5","article-title":"Nephrolithiasis in topiramate users","volume":"39","author":"Maalouf","year":"2011","journal-title":"Urol Res"},{"key":"10.1111\/bcp.12283-BIB0027|bcp12283-cit-0027","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/j.1528-1167.2011.03245.x","article-title":"Incidence of kidney stones with topiramate treatment in pediatric patients","volume":"52","author":"Mahmoud","year":"2011","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0028|bcp12283-cit-0028","first-page":"287","article-title":"Metabolic acidosis in a pediatric patient receiving topiramate. J Pediatr","volume":"8","author":"Malik","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1111\/bcp.12283-BIB0029|bcp12283-cit-0029","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2146\/ajhp070395","article-title":"Hyperchloremic, normal anion-gap, metabolic acidosis due to topiramate","volume":"65","author":"Mathews","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/bcp.12283-BIB0030|bcp12283-cit-0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/FPC.0b013e3283441b95","article-title":"Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors","volume":"21","author":"Mirza","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/bcp.12283-BIB0031|bcp12283-cit-0031","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1345\/aph.1K508","article-title":"Hyperventilation and cerebrospinal fluid acidosis caused by topiramate","volume":"42","author":"Montcriol","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1111\/bcp.12283-BIB0032|bcp12283-cit-0032","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1590\/S0004-282X2000000600007","article-title":"Predisposition to metabolic acidosis induced by topiramate","volume":"58","author":"Montenegro","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1111\/bcp.12283-BIB0033|bcp12283-cit-0033","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2044.2004.03884.x","article-title":"Topiramate induced metabolic acidosis","volume":"59","author":"Ozer","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1111\/bcp.12283-BIB0034|bcp12283-cit-0034","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1528-1157.2002.37201.x","article-title":"Topiramate and metabolic acidosis in infants and toddlers","volume":"43","author":"Philippi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0035|bcp12283-cit-0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1440-1754.2003.00180.x","article-title":"Tolerability of topiramate in children and adolescents","volume":"39","author":"Reith","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"10.1111\/bcp.12283-BIB0036|bcp12283-cit-0036","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/ANA.0b013e31815613ad","article-title":"Intraoperative metabolic acidosis induced by chronic topiramate intake in neurosurgical patients","volume":"20","author":"Rodr\u00edguez","year":"2008","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1111\/bcp.12283-BIB0037|bcp12283-cit-0037","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/ndt\/gfl251","article-title":"Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase","volume":"21","author":"Sacr\u00e9","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/bcp.12283-BIB0038|bcp12283-cit-0038","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jemermed.2008.11.017","article-title":"Severe non-anion gap metabolic acidosis induced by topiramate: a case report","volume":"38","author":"Shiber","year":"2010","journal-title":"J Emerg Med"},{"issue":"Suppl 2","key":"10.1111\/bcp.12283-BIB0039|bcp12283-cit-0039","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1528-1157.1996.tb06029.x","article-title":"Safety of topiramate: adverse events and relationships to dosing","volume":"37","author":"Shorvon","year":"1996","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0040|bcp12283-cit-0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1528-1157.2000.tb00282.x","article-title":"Topiramate in refractory epilepsy: a prospective observational study","volume":"41","author":"Stephen","year":"2000","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0041|bcp12283-cit-0041","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1592\/phco.20.1.105.34662","article-title":"Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy","volume":"20","author":"Stowe","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1111\/bcp.12283-BIB0042|bcp12283-cit-0042","first-page":"656","article-title":"Topiramate-induced renal tubular acidosis. A case report","volume":"28","author":"Sujan","year":"2008","journal-title":"Nefrologia"},{"key":"10.1111\/bcp.12283-BIB0043|bcp12283-cit-0043","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1528-1157.2001.04500.x","article-title":"Topiramate and metabolic acidosis in pediatric epilepsy","volume":"42","author":"Takeoka","year":"2001","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0044|bcp12283-cit-0044","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1528-1157.2002.00602.x","article-title":"Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy","volume":"43","author":"Takeoka","year":"2002","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0045|bcp12283-cit-0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01997718","article-title":"Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial","volume":"17","author":"Tartara","year":"1996","journal-title":"Ital J Neurol Sci"},{"key":"10.1111\/bcp.12283-BIB0046|bcp12283-cit-0046","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.urology.2008.01.042","article-title":"Induction of progressive profound hypocitraturia with increasing doses of topiramate","volume":"72","author":"Warner","year":"2008","journal-title":"Urology"},{"key":"10.1111\/bcp.12283-BIB0047|bcp12283-cit-0047","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.ajkd.2006.07.003","article-title":"Biochemical and stone-risk profiles with topiramate treatment","volume":"48","author":"Welch","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/bcp.12283-BIB0048|bcp12283-cit-0048","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1528-1157.1999.tb00781.x","article-title":"Topiramate and metabolic acidosis","volume":"40","author":"Wilner","year":"1999","journal-title":"Epilepsia"},{"key":"10.1111\/bcp.12283-BIB0049|bcp12283-cit-0049","doi-asserted-by":"crossref","first-page":"91","DOI":"10.33588\/rn.4202.2005125","article-title":"Nefrolitiasis y topiramato","volume":"42","author":"Alarc\u00f3n-Mart\u00ednez","year":"2006","journal-title":"Rev Neurol"},{"key":"10.1111\/bcp.12283-BIB0050|bcp12283-cit-0050","first-page":"403","article-title":"Acidosis metab\u00f3lica inducida por topiramato: a prop\u00f3sito de un caso","volume":"32","author":"Fern\u00e1ndez-de Orueta","year":"2012","journal-title":"Nefrologia"},{"key":"10.1111\/bcp.12283-BIB0051|bcp12283-cit-0051","first-page":"438","article-title":"Relaci\u00f3n entre topiramato y nefrolitiasis en una muestra de pacientes mexicanos con epilepsia refractaria","volume":"9","author":"Guti\u00e9rrez L\u00f3pez","year":"2008","journal-title":"Rev Mex Neuroci"},{"key":"10.1111\/bcp.12283-BIB0052|bcp12283-cit-0052","first-page":"69","article-title":"Topiramato e inhibici\u00f3n de la anhidrasa carb\u00f3nica","volume":"29","author":"L\u00f3pez Gast\u00f3n","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/bcp.12283-BIB0053|bcp12283-cit-0053","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1130-6343(08)75952-X","article-title":"C\u00e1lculo coraliforme secundario a topiramato","volume":"32","author":"L\u00f3pez-Real","year":"2008","journal-title":"Farm Hosp"},{"key":"10.1111\/bcp.12283-BIB0054|bcp12283-cit-0054","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1024\/1661-8157\/a000936","article-title":"Nierenstein durch Migr\u00e4ne","volume":"101","author":"Gerber","year":"2012","journal-title":"Praxis (Bern 1994)"},{"key":"10.1111\/bcp.12283-BIB0055|bcp12283-cit-0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1258\/acb.2011.011281","article-title":"Diuretics: a review","volume":"49","author":"Wile","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/bcp.12283-BIB0056|bcp12283-cit-0056","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI26662","article-title":"Kidney stone disease","volume":"115","author":"Coe","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/bcp.12283-BIB0057|bcp12283-cit-0057","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1172\/JCI103248","article-title":"Observations on the metabolic effects of the carbonic anhydrase inhibitor acetazolamide: mode and rate of recovery from the drug's action","volume":"35","author":"Hanley","year":"1956","journal-title":"J Clin Invest"},{"key":"10.1111\/bcp.12283-BIB0058|bcp12283-cit-0058","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/bmj.327.7425.1179","article-title":"Monitoring drug treatment","volume":"327","author":"Pirmohamed","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/bcp.12283-BIB0059|bcp12283-cit-0059","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0022-5347(17)38496-3","article-title":"Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: responses to citrate","volume":"145","author":"Higashihara","year":"1991","journal-title":"J Urol"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12283","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bcp.12283\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:26:28Z","timestamp":1746044788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12283"}},"subtitle":["Metabolic disturbances on treatment with topiramate"],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bcp.12283","relation":{},"ISSN":["0306-5251"],"issn-type":[{"value":"0306-5251","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}